A Phase I/Ii Study of LY900003, an Antisense Inhibitor of Protein Kinase C- , in Combination With Cisplatin and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0779
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2004
Authors
Publisher
American Association for Cancer Research (AACR)